Literature DB >> 27067318

Mutations Decreasing Intrinsic β-Lactam Resistance Are Linked to Cell Division in the Nosocomial Pathogen Acinetobacter baumannii.

Daniel Knight1, Daniela D Dimitrova2, Susan D Rudin3, Robert A Bonomo3, Philip N Rather4.   

Abstract

Transposon mutagenesis was used to identify novel determinants of intrinsic β-lactam resistance in Acinetobacter baumannii An EZ-Tn5 transposon insertion in a gene corresponding to the A1S_0225 sequence resulted in a 4-fold decrease in resistance to ampicillin, cefotaxime, imipenem, and ceftriaxone but did not alter resistance to other classes of antibiotics. Based on this phenotype, the gene was designated blhA (β-lactam hypersusceptibility). The blhA::EZ-Tn5 mutation conferred a similar phenotype in A. baumannii strain ATCC 17978. The wild-type blhA gene complemented the blhA::EZTn5 insertion and restored β-lactam resistance levels back to wild-type levels. The blhA mutation also increased β-lactam susceptibility in an adeB adeJ double mutant, indicating that the blhA mutation acted independently of these efflux systems to mediate susceptibility. In addition, mRNA levels for the blaOXA and blaADC β-lactamase genes were not altered by the blhA mutation. The blhA mutation resulted in a prominent cell division and morphological defect, with cells exhibiting a highly elongated phenotype, combined with large bulges in some cells. The blhA gene is unique to Acinetobacter and likely represents a novel gene involved in cell division. Three additional mutations, in zipA, zapA, and ftsK, each of which encode predicted cell division proteins, also conferred increased β-lactam susceptibility, indicating a common link between cell division and intrinsic β-lactam resistance in A. baumannii.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27067318      PMCID: PMC4879375          DOI: 10.1128/AAC.00361-16

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  57 in total

1.  Resistance-nodulation-cell division-type efflux pump involved in aminoglycoside resistance in Acinetobacter baumannii strain BM4454.

Authors:  S Magnet; P Courvalin; T Lambert
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

2.  Differential effect of mutational impairment of penicillin-binding proteins 1A and 1B on Escherichia coli strains harboring thermosensitive mutations in the cell division genes ftsA, ftsQ, ftsZ, and pbpB.

Authors:  F García del Portillo; M A de Pedro
Journal:  J Bacteriol       Date:  1990-10       Impact factor: 3.490

Review 3.  Clinical impact and pathogenicity of Acinetobacter.

Authors:  M-L Joly-Guillou
Journal:  Clin Microbiol Infect       Date:  2005-11       Impact factor: 8.067

4.  A conformational switch controls cell wall-remodelling enzymes required for bacterial cell division.

Authors:  Desirée C Yang; Kemin Tan; Andrzej Joachimiak; Thomas G Bernhardt
Journal:  Mol Microbiol       Date:  2012-07-11       Impact factor: 3.501

5.  Analysis and nucleotide sequence of an origin of DNA replication in Acinetobacter calcoaceticus and its use for Escherichia coli shuttle plasmids.

Authors:  M Hunger; R Schmucker; V Kishan; W Hillen
Journal:  Gene       Date:  1990-03-01       Impact factor: 3.688

6.  Coordination of peptidoglycan synthesis and outer membrane constriction during Escherichia coli cell division.

Authors:  Andrew N Gray; Alexander J F Egan; Inge L Van't Veer; Jolanda Verheul; Alexandre Colavin; Alexandra Koumoutsi; Jacob Biboy; A F Maarten Altelaar; Mirjam J Damen; Kerwyn Casey Huang; Jean-Pierre Simorre; Eefjan Breukink; Tanneke den Blaauwen; Athanasios Typas; Carol A Gross; Waldemar Vollmer
Journal:  Elife       Date:  2015-05-07       Impact factor: 8.140

7.  Two cases of necrotizing fasciitis due to Acinetobacter baumannii.

Authors:  Angella Charnot-Katsikas; Amir H Dorafshar; Joyce K Aycock; Michael Z David; Stephen G Weber; Karen M Frank
Journal:  J Clin Microbiol       Date:  2008-10-15       Impact factor: 5.948

8.  Genetic environment and transcription of ampC in an Acinetobacter baumannii clinical isolate.

Authors:  Heidi Segal; E C Nelson; B Gay Elisha
Journal:  Antimicrob Agents Chemother       Date:  2004-02       Impact factor: 5.191

9.  A broad-host-range Flp-FRT recombination system for site-specific excision of chromosomally-located DNA sequences: application for isolation of unmarked Pseudomonas aeruginosa mutants.

Authors:  T T Hoang; R R Karkhoff-Schweizer; A J Kutchma; H P Schweizer
Journal:  Gene       Date:  1998-05-28       Impact factor: 3.688

10.  LytM-domain factors are required for daughter cell separation and rapid ampicillin-induced lysis in Escherichia coli.

Authors:  Tsuyoshi Uehara; Thuy Dinh; Thomas G Bernhardt
Journal:  J Bacteriol       Date:  2009-06-12       Impact factor: 3.490

View more
  13 in total

1.  Strategic Approaches to Overcome Resistance against Gram-Negative Pathogens Using β-Lactamase Inhibitors and β-Lactam Enhancers: Activity of Three Novel Diazabicyclooctanes WCK 5153, Zidebactam (WCK 5107), and WCK 4234.

Authors:  Krisztina M Papp-Wallace; Nhu Q Nguyen; Michael R Jacobs; Christopher R Bethel; Melissa D Barnes; Vijay Kumar; Saralee Bajaksouzian; Susan D Rudin; Philip N Rather; Satish Bhavsar; Tadiparthi Ravikumar; Prasad K Deshpande; Vijay Patil; Ravindra Yeole; Sachin S Bhagwat; Mahesh V Patel; Focco van den Akker; Robert A Bonomo
Journal:  J Med Chem       Date:  2018-04-20       Impact factor: 7.446

Review 2.  Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges.

Authors:  Darren Wong; Travis B Nielsen; Robert A Bonomo; Paul Pantapalangkoor; Brian Luna; Brad Spellberg
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

Review 3.  Evasion of Antimicrobial Activity in Acinetobacter baumannii by Target Site Modifications: An Effective Resistance Mechanism.

Authors:  Arturo Martínez-Trejo; Juan Manuel Ruiz-Ruiz; Luis Uriel Gonzalez-Avila; Andrés Saldaña-Padilla; Cecilia Hernández-Cortez; Miguel Angel Loyola-Cruz; Juan Manuel Bello-López; Graciela Castro-Escarpulli
Journal:  Int J Mol Sci       Date:  2022-06-13       Impact factor: 6.208

4.  Characterization of RelA in Acinetobacter baumannii.

Authors:  María Pérez-Varela; Aimee R P Tierney; Ju-Sim Kim; Andrés Vázquez-Torres; Philip Rather
Journal:  J Bacteriol       Date:  2020-05-27       Impact factor: 3.490

Review 5.  Biology of Acinetobacter baumannii: Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment Options.

Authors:  Chang-Ro Lee; Jung Hun Lee; Moonhee Park; Kwang Seung Park; Il Kwon Bae; Young Bae Kim; Chang-Jun Cha; Byeong Chul Jeong; Sang Hee Lee
Journal:  Front Cell Infect Microbiol       Date:  2017-03-13       Impact factor: 5.293

6.  Essential gene deletions producing gigantic bacteria.

Authors:  Jeannie Bailey; Julie Cass; Joe Gasper; Ngoc-Diep Ngo; Paul Wiggins; Colin Manoil
Journal:  PLoS Genet       Date:  2019-06-10       Impact factor: 5.917

7.  Antibiotic susceptibility signatures identify potential antimicrobial targets in the Acinetobacter baumannii cell envelope.

Authors:  Edward Geisinger; Nadav J Mortman; Yunfei Dai; Murat Cokol; Sapna Syal; Andrew Farinha; Delaney G Fisher; Amy Y Tang; David W Lazinski; Stephen Wood; Jon Anthony; Tim van Opijnen; Ralph R Isberg
Journal:  Nat Commun       Date:  2020-09-09       Impact factor: 14.919

8.  Broad Spectrum Antibiotic Xanthocillin X Effectively Kills Acinetobacter baumannii via Dysregulation of Heme Biosynthesis.

Authors:  Ines Hübner; Justin A Shapiro; Jörn Hoßmann; Jonas Drechsel; Stephan M Hacker; Philip N Rather; Dietmar H Pieper; William M Wuest; Stephan A Sieber
Journal:  ACS Cent Sci       Date:  2021-01-20       Impact factor: 14.553

9.  Proteomic Analyses of Acinetobacter baumannii Clinical Isolates to Identify Drug Resistant Mechanism.

Authors:  Ping Wang; Ren-Qing Li; Lei Wang; Wen-Tao Yang; Qing-Hua Zou; Di Xiao
Journal:  Front Cell Infect Microbiol       Date:  2021-02-24       Impact factor: 5.293

10.  Genetic Dissection of Antibiotic Adjuvant Activity.

Authors:  J Bailey; L Gallagher; W T Barker; V B Hubble; J Gasper; C Melander; C Manoil
Journal:  mBio       Date:  2022-01-18       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.